IRF1 and atherosclerosis: For example, silencing IRF1 alleviated atherosclerosis in ApoEKO mice by regulating lipid metabolism and foam cell formation (Du et al., 2019) and highly suggests that IRF1 activation is a risk factor for the occurrence and development of atherosclerosis.